Cyanosis surgery: Difference between revisions
No edit summary |
|||
(55 intermediate revisions by 2 users not shown) | |||
Line 1: | Line 1: | ||
__NOTOC__ | __NOTOC__ | ||
{{Cyanosis}} | {{Cyanosis}} | ||
{{CMG}}; {{AE}} | {{CMG}}; {{AE}} {{Sara.Zand}} | ||
==Overview== | |||
Cardiac defects causing [[central cyanosis]] include: [[Transposition of the great arteries]], [[Tetralogy of fallot]], [[Tricuspid atresia]], [[Truncus arteriosus]],[[Total anomalous pulmonary venous connection]], [[Ebstein anomaly]], critical [[Pulmonary stenosis]] or atresia, functional [[single ventricle]]. The palliative surgical shunt maybe done in such lesions to increase [[pulmonary blood flow]] even in the presence of [[cyanosis]]. Complete repair procedure leads to relief of cyanosis and shunt and also has long term complications. | |||
== Recommendation for surgery in [[cyanotic heart disease]] == | == Recommendation for surgery in [[cyanotic heart disease]] == | ||
The table shows indications for surgery in [[cyanotic congenital heart disease]] according to 2018 [[AHA/ACC Guideline]]:<ref name="StoutDaniels2019">{{cite journal|last1=Stout|first1=Karen K.|last2=Daniels|first2=Curt J.|last3=Aboulhosn|first3=Jamil A.|last4=Bozkurt|first4=Biykem|last5=Broberg|first5=Craig S.|last6=Colman|first6=Jack M.|last7=Crumb|first7=Stephen R.|last8=Dearani|first8=Joseph A.|last9=Fuller|first9=Stephanie|last10=Gurvitz|first10=Michelle|last11=Khairy|first11=Paul|last12=Landzberg|first12=Michael J.|last13=Saidi|first13=Arwa|last14=Valente|first14=Anne Marie|last15=Van Hare|first15=George F.|title=2018 AHA/ACC Guideline for the Management of Adults With Congenital Heart Disease: A Report of the American College of Cardiology/American Heart Association Task Force on Clinical Practice Guidelines|journal=Circulation|volume=139|issue=14|year=2019|issn=0009-7322|doi=10.1161/CIR.0000000000000603}}</ref> | The table shows indications for surgery in [[cyanotic congenital heart disease]] according to 2018 [[AHA/ACC Guideline]]:<ref name="StoutDaniels2019">{{cite journal|last1=Stout|first1=Karen K.|last2=Daniels|first2=Curt J.|last3=Aboulhosn|first3=Jamil A.|last4=Bozkurt|first4=Biykem|last5=Broberg|first5=Craig S.|last6=Colman|first6=Jack M.|last7=Crumb|first7=Stephen R.|last8=Dearani|first8=Joseph A.|last9=Fuller|first9=Stephanie|last10=Gurvitz|first10=Michelle|last11=Khairy|first11=Paul|last12=Landzberg|first12=Michael J.|last13=Saidi|first13=Arwa|last14=Valente|first14=Anne Marie|last15=Van Hare|first15=George F.|title=2018 AHA/ACC Guideline for the Management of Adults With Congenital Heart Disease: A Report of the American College of Cardiology/American Heart Association Task Force on Clinical Practice Guidelines|journal=Circulation|volume=139|issue=14|year=2019|issn=0009-7322|doi=10.1161/CIR.0000000000000603}}</ref> | ||
<ref name="ShiZhu2017">{{cite journal|last1=Shi|first1=Guocheng|last2=Zhu|first2=Zhongqun|last3=Chen|first3=Jimei|last4=Ou|first4=Yanqiu|last5=Hong|first5=Haifa|last6=Nie|first6=Zhiqiang|last7=Zhang|first7=Haibo|last8=Liu|first8=Xiaoqing|last9=Zheng|first9=Jinghao|last10=Sun|first10=Qi|last11=Liu|first11=Jinfen|last12=Chen|first12=Huiwen|last13=Zhuang|first13=Jian|title=Total Anomalous Pulmonary Venous Connection|journal=Circulation|volume=135|issue=1|year=2017|pages=48–58|issn=0009-7322|doi=10.1161/CIRCULATIONAHA.116.023889}}</ref><ref>{{cite journal|doi=10.4103/2F0974-2069.157025}}</ref><ref name="Attenhofer JostConnolly2007">{{cite journal|last1=Attenhofer Jost|first1=Christine H.|last2=Connolly|first2=Heidi M.|last3=Dearani|first3=Joseph A.|last4=Edwards|first4=William D.|last5=Danielson|first5=Gordon K.|title=Ebstein’s Anomaly|journal=Circulation|volume=115|issue=2|year=2007|pages=277–285|issn=0009-7322|doi=10.1161/CIRCULATIONAHA.106.619338}}</ref><ref name="pmid27275259">{{cite journal |vauthors=Idrizi S, Milev I, Zafirovska P, Tosheski G, Zimbakov Z, Ampova-Sokolov V, Angjuseva T, Mitrev Z |title=Interventional Treatment of Pulmonary Valve Stenosis: A Single Center Experience |journal=Open Access Maced J Med Sci |volume=3 |issue=3 |pages=408–12 |date=September 2015 |pmid=27275259 |pmc=4877828 |doi=10.3889/oamjms.2015.089 |url=}}</ref> | |||
'''<span style="font-size:85%">'''Abbreviations:''' | '''<span style="font-size:85%">'''Abbreviations:''' | ||
'''TGA:''' [[Transposition of great arteries]]; | '''d-TGA:''' [[dextro-Transposition of great arteries]]; | ||
'''PDA:''' [[Patent ductus arteriosus]] ; | '''PDA:''' [[Patent ductus arteriosus]] ; | ||
'''ASD:''' [[Atrial septal defect]]; | '''ASD:''' [[Atrial septal defect]]; | ||
Line 19: | Line 24: | ||
'''VF:''' [[Ventricular fibrillation]]; | '''VF:''' [[Ventricular fibrillation]]; | ||
'''PR:''' [[Pulmonary regurgitation]]; | '''PR:''' [[Pulmonary regurgitation]]; | ||
'''RVOT:''' [[Right ventricular outflow tract]]; | |||
'''CMR:''' [[Cardiovascular magnetic resonance]]; | |||
'''SVC:''' [[Superior vena cava]]; | |||
'''IVC:''' [[Inferior vena cava]]; | |||
</span> | </span> | ||
<br> | <br> | ||
Line 37: | Line 46: | ||
<span style="font-size:85%;color:red"> [[Definition|<span style="color:red">Definition:</span>]] Abnormal connection between pulmonary veins and systemic veins leading to right heart volume overload such as ASD</span><br> | <span style="font-size:85%;color:red"> [[Definition|<span style="color:red">Definition:</span>]] Abnormal connection between pulmonary veins and systemic veins leading to right heart volume overload such as ASD</span><br> | ||
|- | |- | ||
|style="font-size: 100; padding: 0 5px; background: #B8B8B8" align=left |''' Indications for surgery in [[Anomalous Pulmonary Venous Connections]] ([[TAPVC]])'''([[ACC AHA guidelines classification scheme|Class 2a, Level of Evidence B]]) :''' | |style="font-size: 100; padding: 0 5px; background: #B8B8B8" align=left |''' Indications for [[surgery]] in [[Anomalous Pulmonary Venous Connections]] ([[TAPVC]])'''([[ACC AHA guidelines classification scheme|Class 2a, Level of Evidence B]]) :''' | ||
|- | |- | ||
|style="padding: 0 5px; font-size: 100%; background: #F5F5F5; width: 70%" align=left| | |style="padding: 0 5px; font-size: 100%; background: #F5F5F5; width: 70%" align=left| | ||
❑ Asymptomatic adults with [[right ventricle]] volume overload<br> | ❑ Asymptomatic adults with [[right ventricle]] volume overload<br> | ||
❑ Large left to right shunt( QP/QS > 1.5/1 <br> | ❑ Large left to right shunt( QP/QS > 1.5/1 <br> | ||
❑[[Pulmonary artery pressure]] <50% systemic pressure and [[pulmonary artery resistance]] <1/3 systemic resistance<br> | ❑ [[Pulmonary artery pressure]] <50% systemic pressure and [[pulmonary artery resistance]] <1/3 systemic resistance<br> | ||
❑ Evidence of [[Right ventricle]] volume overload and QP/QS>1.5/1<br> | ❑ Evidence of [[Right ventricle]] volume overload and QP/QS>1.5/1<br> | ||
|- | |- | ||
|style="font-size: 100; padding: 0 5px; background: #B8B8B8" align=left |''' Indications for surgical repair or reoperation in [[Ebstein anomaly]] : ([[ACC AHA guidelines classification scheme|Class I, Level of Evidence B]])''' | |style="font-size: 100; padding: 0 5px; background: #B8B8B8" align=left |''' Indications for [[surgical]] repair or reoperation in [[Ebstein anomaly]] : ([[ACC AHA guidelines classification scheme|Class I, Level of Evidence B]])''' | ||
|- | |- | ||
|style="padding: 0 5px; font-size: 100%; background: #F5F5F5; width: 70%" align=left| | |style="padding: 0 5px; font-size: 100%; background: #F5F5F5; width: 70%" align=left| | ||
Line 54: | Line 63: | ||
<span style="font-size:85%;color:red"> [[Definition|<span style="color:red">Definition:</span>]] Malformation of tricuspid valve and right ventricle , atrialization of right ventricle, huge right atrium, accompanied by ASD, VSD, PS</span><br> | <span style="font-size:85%;color:red"> [[Definition|<span style="color:red">Definition:</span>]] Malformation of tricuspid valve and right ventricle , atrialization of right ventricle, huge right atrium, accompanied by ASD, VSD, PS</span><br> | ||
|- | |- | ||
|style="font-size: 100; padding: 0 5px; background: #B8B8B8" align=left |'''Indications for surgical repair or reoperation in [[Ebstein anomaly]]:([[ACC AHA guidelines classification scheme|Class 2a, Level of Evidence B]])''' | |style="font-size: 100; padding: 0 5px; background: #B8B8B8" align=left |'''Indications for [[surgical]] repair or reoperation in [[Ebstein anomaly]]:([[ACC AHA guidelines classification scheme|Class 2a, Level of Evidence B]])''' | ||
|- | |- | ||
|style="padding: 0 5px; font-size: 100%; background: #F5F5F5; width: 70%" align=left| | |style="padding: 0 5px; font-size: 100%; background: #F5F5F5; width: 70%" align=left| | ||
Line 90: | Line 99: | ||
❑ Moderate to severe [[PR]] with other lesions requiring surgery in repaired [[TOF]]<br> | ❑ Moderate to severe [[PR]] with other lesions requiring surgery in repaired [[TOF]]<br> | ||
❑ Moderate to severe [[PR]] with ventricular tachycardia requiring arrhythmia management in repaired [[TOF]]<br> | ❑ Moderate to severe [[PR]] with ventricular tachycardia requiring arrhythmia management in repaired [[TOF]]<br> | ||
<span style="font-size:85%;color:red"> [[Other lesions requiring surgery|<span style="color:red"> Other lesions requiring surgery:</span>]] RVOT aneurysm, TR, branch PA stenosis, residual VSD, arrhythmia ablation, coronary artery revascularization, aortic root replacement </span><br> | |||
|- | |- | ||
|style="font-size: 100; padding: 0 5px; background: #B8B8B8" align=left |'''Indication for [[Tricuspid valve replacement ]] in [[CCTGA]] : ([[ACC AHA guidelines classification scheme|Class I, Level of Evidence B]])''' | |style="font-size: 100; padding: 0 5px; background: #B8B8B8" align=left |'''Indication for [[Tricuspid valve replacement ]] in [[CCTGA]] : ([[ACC AHA guidelines classification scheme|Class I, Level of Evidence B]])''' | ||
Line 100: | Line 110: | ||
|style="padding: 0 5px; font-size: 100%; background: #F5F5F5; width: 70%" align=left| | |style="padding: 0 5px; font-size: 100%; background: #F5F5F5; width: 70%" align=left| | ||
❑ Asymptomatic severe [[tricuspid regurgitation]] accompanied by mildly dilated systemic [[ventricle]]<br> | ❑ Asymptomatic severe [[tricuspid regurgitation]] accompanied by mildly dilated systemic [[ventricle]]<br> | ||
<span style="font-size:85%;color:red"> [[Definition|<span style="color:red"> Definition:</span>]] Atrioventricular discordance and ventriculoarterial discordance leading to physiologic corrected circulation accompanied by VSD(75%), pulmonary or subpulmonary stenosis(75%),left sided tricuspid and Ebstein like valve anomalies(75%) </span><br> | |||
|- | |- | ||
|style="font-size: 100; padding: 0 5px; background: #B8B8B8" align=left |'''Indication for conduit intervention/replacement in [[CCTGA]] : ([[ACC AHA guidelines classification scheme|Class 2b, Level of Evidence B]])''' | |style="font-size: 100; padding: 0 5px; background: #B8B8B8" align=left |'''Indication for conduit intervention/replacement in [[CCTGA]] : ([[ACC AHA guidelines classification scheme|Class 2b, Level of Evidence B]])''' | ||
Line 112: | Line 123: | ||
❑ Surgical repair is recommended if balloon valvoplasty in indicated patients failed <br> | ❑ Surgical repair is recommended if balloon valvoplasty in indicated patients failed <br> | ||
|- | |- | ||
|style="font-size: 100; padding: 0 5px; background: #B8B8B8" align=left |'''Indication for [[Balloon valvoplasty ]] in [[Pulmonary | |style="font-size: 100; padding: 0 5px; background: #B8B8B8" align=left |'''Indication for [[Balloon valvoplasty]] in [[Pulmonary Stenosis]] : ([[ACC AHA guidelines classification scheme|Class 2a , Level of Evidence C]])''' | ||
|- | |- | ||
|style="padding: 0 5px; font-size: 100%; background: #F5F5F5; width: 70%" align=left| | |style="padding: 0 5px; font-size: 100%; background: #F5F5F5; width: 70%" align=left| | ||
❑ Asymptomatic severe [[valvular PS]]<br> | ❑ Asymptomatic severe [[valvular PS]]<br> | ||
|- | |- | ||
|style="font-size: 100; padding: 0 5px; background: #B8B8B8" align=left |'''Indication for [[Dilation and | |style="font-size: 100; padding: 0 5px; background: #B8B8B8" align=left |'''Indication for [[Dilation and Stenting]] in [[Peripheral Pulmonary Stenosis]] : ([[ACC AHA guidelines classification scheme|Class 2a, Level of Evidence B]])''' | ||
|- | |- | ||
|style="padding: 0 5px; font-size: 100%; background: #F5F5F5; width: 70%" align=left| | |style="padding: 0 5px; font-size: 100%; background: #F5F5F5; width: 70%" align=left| | ||
❑ In adult with branch and peripheral [[PS]] , [[pulmonary artery]] dilation and stenting is recommended | ❑ In an adult with branch and peripheral [[PS]], [[pulmonary artery]] dilation and stenting is recommended | ||
|} | |} | ||
== Surgical procedures in [[d-TGA]] and [[Tricuspid Atresia]] == | |||
{| class="wikitable" | |||
|- | |||
! Surgical management in [[d-TGA]] || Surgical management in [[Tricuspid Atresia]] | |||
|- | |||
! Life-saving balloon atrial septostomy in neonatal period||Blalock Taussig shunt | |||
|- | |||
|Connection between right and the left system is necessary for the life | |||
|| | |||
*In the first 8 weeks of birth for transferring the systemic blood to the pulmonary circulation in the neonate with cyanosia and pulmonary obstruction and normal positioning [[aorta]] and [[pulmonary artery]]<ref name="pmid26260095">{{cite journal |vauthors=Aykanat A, Yavuz T, Özalkaya E, Topçuoğlu S, Ovalı F, Karatekin G |title=Long-Term Prostaglandin E1 Infusion for Newborns with Critical Congenital Heart Disease |journal=Pediatr Cardiol |volume=37 |issue=1 |pages=131–4 |date=January 2016 |pmid=26260095 |doi=10.1007/s00246-015-1251-0 |url=}}</ref><span style="font-size:85%;color:red"> [[Definition|<span style="color:red"> Definition:</span>]] Absence of trisuspid valve and right ventricle hypoplasia,connection via ASD is necessary </span><br> | |||
|- | |||
! Atrial switch procedure|| [[Pulmonary artery]] banding.<ref name="pmid30811802">{{cite journal |vauthors=Boucek DM, Qureshi AM, Goldstein BH, Petit CJ, Glatz AC |title=Blalock-Taussig shunt versus patent ductus arteriosus stent as first palliation for ductal-dependent pulmonary circulation lesions: A review of the literature |journal=Congenit Heart Dis |volume=14 |issue=1 |pages=105–109 |date=January 2019 |pmid=30811802 |doi=10.1111/chd.12707 |url=}}</ref> | |||
|- | |||
| | |||
* Mustard procedure (baffle made of Dacron or [[pericardium]]) or [[Senning]] procedure(atrial flap)<ref name="VejlstrupSørensen2015">{{cite journal|last1=Vejlstrup|first1=Niels|last2=Sørensen|first2=Keld|last3=Mattsson|first3=Eva|last4=Thilén|first4=Ulf|last5=Kvidal|first5=Per|last6=Johansson|first6=Bengt|last7=Iversen|first7=Kasper|last8=Søndergaard|first8=Lars|last9=Dellborg|first9=Mikael|last10=Eriksson|first10=Peter|title=Long-Term Outcome of Mustard/Senning Correction for Transposition of the Great Arteries in Sweden and Denmark|journal=Circulation|volume=132|issue=8|year=2015|pages=633–638|issn=0009-7322|doi=10.1161/CIRCULATIONAHA.114.010770}}</ref> | |||
* The most common procedure in older patients | |||
* Blood is diverted at the atrial level into the physiologic ventricle | |||
* Systemic venous return is diverted into [[left ventricle]] through [[mitral valve]] | |||
* Pulmonary venous return is directed into [[right ventricle]] through [[tricuspid valve]] | |||
<span style="font-size:85%;color:red"> [[d-TGA definition|<span style="color:red"> d-TGA definition:</span>]] Aorta arises from right ventricle and pulmonary artery arises from left ventricle </span><br> | |||
|| | |||
* Useful in overflow [[pulmonary artery]] coming from [[left ventricle]] for lowering the [[pulmonary blood flow]] | |||
|- | |||
! Arterial switch procedure || Bidirectional Glenn shunt | |||
|- | |||
| | |||
*Transection and anastomoses of [[aorta]] and [[pulmonary artery ]] to the contralateral ventricle | |||
* Closure of the [[VSD]] | |||
* Transposioning of the [[coronary artrie]] | |||
* Benefit is the restoration of [[left ventricular]] systolic function | |||
|| | |||
*Useful in older children for blood transferring from [[SVC]] to [[pulmonary artery]] | |||
|- | |||
! Rastelli procedure|| Fontan procedure<ref name="pmid8238751">{{cite journal |vauthors=Norwood WI, Jacobs ML |title=Fontan's procedure in two stages |journal=Am. J. Surg. |volume=166 |issue=5 |pages=548–51 |date=November 1993 |pmid=8238751 |doi=10.1016/s0002-9610(05)81151-1 |url=}}</ref><ref name="d'UdekemIyengar2007">{{cite journal|last1=d'Udekem|first1=Y.|last2=Iyengar|first2=A. J.|last3=Cochrane|first3=A. D.|last4=Grigg|first4=L. E.|last5=Ramsay|first5=J. M.|last6=Wheaton|first6=G. R.|last7=Penny|first7=D. J.|last8=Brizard|first8=C. P.|title=The Fontan Procedure: Contemporary Techniques Have Improved Long-Term Outcomes|journal=Circulation|volume=116|issue=11_suppl|year=2007|pages=I-157–I-164|issn=0009-7322|doi=10.1161/CIRCULATIONAHA.106.676445}}</ref> | |||
* | |- | ||
| | |||
* Systemic to pulmonary artery shunt when [[pulmonary blood flow]] decreases<ref>{{cite journal|doi=10.1177/2F2150135118817765}}</ref> | |||
* Useful in infants with [[TGA]] and [[VSD]] and [[PS]] | |||
*Function: Re-direction of ventricular outflow | |||
*Placement a conduit between [[right ventricle]] and [[pulmonary artery]] and also a baffle between [[left ventricle]] and [[aorta]] | |||
* Survival rate is poor compared with mustard and arterial switch | |||
|| | |||
*Useful in older children aged 2-3 | |||
* A conduit for transferring blood from [[IVC]] to [[pulmonary artery]] | |||
|- | |||
|} | |||
== Palliative Systemic-to-Pulmonary shunts == | |||
{| class="wikitable" | |||
|- | |||
! Arterial | |||
|- | |||
| [[Blalock-taussing-Thomas shunt]] ([[subclavian artery]] to [[pulmonary artery]]) | |||
|- | |||
| [[Central shunt]] ([[aorta]] to [[pulmonary artery]]) | |||
|- | |||
| [[Potts shunt]] (descending aorta to [[left pulmonary artery]] | |||
|- | |||
| [[Waterston shunt]] ([[Ascending aorta]] to [[right pulmonary artery]]) | |||
|- | |||
! Venous | |||
|- | |||
| Glenn shunt ([[SVC]] to the ipsilateral [[pulmonary artery]]) | |||
|- | |||
| Bidirectional cavopulmonary (Glenn) shunt( end to side [[SVC]] to [[left pulmonary artery]] and [[right pulmonary artery]] shunt) | |||
|} | |||
* [[Right ventricle]]–to-[[pulmonary artery]] conduits is recommended in severe [[RVOT]] obstruction such as [[pulmonary atresia]]. | |||
* theses conduits may be homografts or prosthetic conduits with bioprosthetic valves using within the conduit. | |||
*Common complications of the conduits may include the following: | |||
:*Kinking | |||
:*[[Aneurysmal dilation]] | |||
:*Conduit dysfunction over time | |||
:*Progressive stenosis within the [[conduit]] or at the [[valve]] | |||
:*Valvular [[regurgitation]] | |||
==References== | ==References== | ||
{{Reflist|2}} | {{Reflist|2}} | ||
[[Category:Up To Date]] | |||
[[Category: |
Latest revision as of 14:24, 4 March 2021
Cyanosis Microchapters |
Diagnosis |
---|
Treatment |
Case Studies |
Cyanosis surgery On the Web |
American Roentgen Ray Society Images of Cyanosis surgery |
Editor-In-Chief: C. Michael Gibson, M.S., M.D. [1]; Associate Editor(s)-in-Chief: Sara Zand, M.D.[2]
Overview
Cardiac defects causing central cyanosis include: Transposition of the great arteries, Tetralogy of fallot, Tricuspid atresia, Truncus arteriosus,Total anomalous pulmonary venous connection, Ebstein anomaly, critical Pulmonary stenosis or atresia, functional single ventricle. The palliative surgical shunt maybe done in such lesions to increase pulmonary blood flow even in the presence of cyanosis. Complete repair procedure leads to relief of cyanosis and shunt and also has long term complications.
Recommendation for surgery in cyanotic heart disease
The table shows indications for surgery in cyanotic congenital heart disease according to 2018 AHA/ACC Guideline:[1] [2][3][4][5]
Abbreviations:
d-TGA: dextro-Transposition of great arteries;
PDA: Patent ductus arteriosus ;
ASD: Atrial septal defect;
VSD: Ventricular septal defect;
TAPVC: Total anomalous pulmonary venous connection;
TOF: Tetralogy of fallot;
CCTGA: Congenitally corrected transposition of the great arteries;
PS: Pulmonary stenosis;
AF: Atrial fibrillation;
VF: Ventricular fibrillation;
PR: Pulmonary regurgitation;
RVOT: Right ventricular outflow tract;
CMR: Cardiovascular magnetic resonance;
SVC: Superior vena cava;
IVC: Inferior vena cava;
Recommendation for surgery in cyanotic congenital heart disease |
Indications for repair of a scimitar vein in Anomalous pulmonary venous connection (TAPVC) (Class I, Level of Evidence B ): |
❑ Decreased functional capacity |
Indications for surgery in Anomalous Pulmonary Venous Connections (TAPVC)(Class 2a, Level of Evidence B) : |
❑ Asymptomatic adults with right ventricle volume overload |
Indications for surgical repair or reoperation in Ebstein anomaly : (Class I, Level of Evidence B) |
❑ Significant tricuspid regurgitation in the presence of the following: |
Indications for surgical repair or reoperation in Ebstein anomaly:(Class 2a, Level of Evidence B) |
❑ Significant tricuspid regurgitation in the presence of the following: |
Indication for Glenn anastomousis at the time of repair in Ebstein anomaly : (Class 2b, Level of Evidence B) |
❑ Severe right ventricle dilation |
Indication for pulmonary valve replacement ( surgical or percutaneous in Tetralogy of fallot (Class I, Level of Evidence B): |
❑ Symptomatic Moderate to severe pulmonary regurgitation after repaired TOF in which symptoms can not be explained otherwise. |
Indication for Pulmonary valve replacement ( surgical or percutaneous in Tetralogy of fallot : (Class 2a, Level of Evidence B) |
❑ Asymptomatic moderate to severe pulmonary regurgitation after repaired TOF |
Indication for Pulmonary valve replacement (surgical) in Tetralogy of fallot : (Class 2b, Level of Evidence C) |
❑ Moderate to severe PR with other lesions requiring surgery in repaired TOF |
Indication for Tricuspid valve replacement in CCTGA : (Class I, Level of Evidence B) |
❑ Symptomatic severe tricuspid regurgitaion accompanied by preserved or mildly systolic dysfunction of systemic ventricle |
Indication for Tricuspid valve replacement in CCTGA : (Class 2a, Level of Evidence C) |
❑ Asymptomatic severe tricuspid regurgitation accompanied by mildly dilated systemic ventricle |
Indication for conduit intervention/replacement in CCTGA : (Class 2b, Level of Evidence B) |
❑ Symptomatic subpulmonary left ventricle to pulmonary artery conduit dysfunction |
Indication for Balloon valvoplasty in Pulmonary stenosis : (Class I , Level of Evidence B) |
❑ In adult with moderate to severe valvular PS with symptoms of heart failure, cyanosis from intracardiac right to left shunt, exercise intolerance |
Indication for Balloon valvoplasty in Pulmonary Stenosis : (Class 2a , Level of Evidence C) |
❑ Asymptomatic severe valvular PS |
Indication for Dilation and Stenting in Peripheral Pulmonary Stenosis : (Class 2a, Level of Evidence B) |
❑ In an adult with branch and peripheral PS, pulmonary artery dilation and stenting is recommended |
Surgical procedures in d-TGA and Tricuspid Atresia
Surgical management in d-TGA | Surgical management in Tricuspid Atresia |
---|---|
Life-saving balloon atrial septostomy in neonatal period | Blalock Taussig shunt |
Connection between right and the left system is necessary for the life |
|
Atrial switch procedure | Pulmonary artery banding.[7] |
d-TGA definition: Aorta arises from right ventricle and pulmonary artery arises from left ventricle |
|
Arterial switch procedure | Bidirectional Glenn shunt |
|
|
Rastelli procedure | Fontan procedure[9][10]
|
|
|
Palliative Systemic-to-Pulmonary shunts
Arterial |
---|
Blalock-taussing-Thomas shunt (subclavian artery to pulmonary artery) |
Central shunt (aorta to pulmonary artery) |
Potts shunt (descending aorta to left pulmonary artery |
Waterston shunt (Ascending aorta to right pulmonary artery) |
Venous |
Glenn shunt (SVC to the ipsilateral pulmonary artery) |
Bidirectional cavopulmonary (Glenn) shunt( end to side SVC to left pulmonary artery and right pulmonary artery shunt) |
- Right ventricle–to-pulmonary artery conduits is recommended in severe RVOT obstruction such as pulmonary atresia.
- theses conduits may be homografts or prosthetic conduits with bioprosthetic valves using within the conduit.
- Common complications of the conduits may include the following:
- Kinking
- Aneurysmal dilation
- Conduit dysfunction over time
- Progressive stenosis within the conduit or at the valve
- Valvular regurgitation
References
- ↑ Stout, Karen K.; Daniels, Curt J.; Aboulhosn, Jamil A.; Bozkurt, Biykem; Broberg, Craig S.; Colman, Jack M.; Crumb, Stephen R.; Dearani, Joseph A.; Fuller, Stephanie; Gurvitz, Michelle; Khairy, Paul; Landzberg, Michael J.; Saidi, Arwa; Valente, Anne Marie; Van Hare, George F. (2019). "2018 AHA/ACC Guideline for the Management of Adults With Congenital Heart Disease: A Report of the American College of Cardiology/American Heart Association Task Force on Clinical Practice Guidelines". Circulation. 139 (14). doi:10.1161/CIR.0000000000000603. ISSN 0009-7322.
- ↑ Shi, Guocheng; Zhu, Zhongqun; Chen, Jimei; Ou, Yanqiu; Hong, Haifa; Nie, Zhiqiang; Zhang, Haibo; Liu, Xiaoqing; Zheng, Jinghao; Sun, Qi; Liu, Jinfen; Chen, Huiwen; Zhuang, Jian (2017). "Total Anomalous Pulmonary Venous Connection". Circulation. 135 (1): 48–58. doi:10.1161/CIRCULATIONAHA.116.023889. ISSN 0009-7322.
- ↑ . doi:10.4103/2F0974-2069.157025. Missing or empty
|title=
(help) - ↑ Attenhofer Jost, Christine H.; Connolly, Heidi M.; Dearani, Joseph A.; Edwards, William D.; Danielson, Gordon K. (2007). "Ebstein's Anomaly". Circulation. 115 (2): 277–285. doi:10.1161/CIRCULATIONAHA.106.619338. ISSN 0009-7322.
- ↑ Idrizi S, Milev I, Zafirovska P, Tosheski G, Zimbakov Z, Ampova-Sokolov V, Angjuseva T, Mitrev Z (September 2015). "Interventional Treatment of Pulmonary Valve Stenosis: A Single Center Experience". Open Access Maced J Med Sci. 3 (3): 408–12. doi:10.3889/oamjms.2015.089. PMC 4877828. PMID 27275259.
- ↑ Aykanat A, Yavuz T, Özalkaya E, Topçuoğlu S, Ovalı F, Karatekin G (January 2016). "Long-Term Prostaglandin E1 Infusion for Newborns with Critical Congenital Heart Disease". Pediatr Cardiol. 37 (1): 131–4. doi:10.1007/s00246-015-1251-0. PMID 26260095.
- ↑ Boucek DM, Qureshi AM, Goldstein BH, Petit CJ, Glatz AC (January 2019). "Blalock-Taussig shunt versus patent ductus arteriosus stent as first palliation for ductal-dependent pulmonary circulation lesions: A review of the literature". Congenit Heart Dis. 14 (1): 105–109. doi:10.1111/chd.12707. PMID 30811802.
- ↑ Vejlstrup, Niels; Sørensen, Keld; Mattsson, Eva; Thilén, Ulf; Kvidal, Per; Johansson, Bengt; Iversen, Kasper; Søndergaard, Lars; Dellborg, Mikael; Eriksson, Peter (2015). "Long-Term Outcome of Mustard/Senning Correction for Transposition of the Great Arteries in Sweden and Denmark". Circulation. 132 (8): 633–638. doi:10.1161/CIRCULATIONAHA.114.010770. ISSN 0009-7322.
- ↑ Norwood WI, Jacobs ML (November 1993). "Fontan's procedure in two stages". Am. J. Surg. 166 (5): 548–51. doi:10.1016/s0002-9610(05)81151-1. PMID 8238751.
- ↑ d'Udekem, Y.; Iyengar, A. J.; Cochrane, A. D.; Grigg, L. E.; Ramsay, J. M.; Wheaton, G. R.; Penny, D. J.; Brizard, C. P. (2007). "The Fontan Procedure: Contemporary Techniques Have Improved Long-Term Outcomes". Circulation. 116 (11_suppl): I-157–I-164. doi:10.1161/CIRCULATIONAHA.106.676445. ISSN 0009-7322.
- ↑ . doi:10.1177/2F2150135118817765. Missing or empty
|title=
(help)